144 related articles for article (PubMed ID: 1691624)
1. The budding of defective human immunodeficiency virus type 1 (HIV-1) particles from cell clones persistently infected with HIV-1.
Goto T; Ikuta K; Zhang JJ; Morita C; Sano K; Komatsu M; Fujita H; Kato S; Nakai M
Arch Virol; 1990; 111(1-2):87-101. PubMed ID: 1691624
[TBL] [Abstract][Full Text] [Related]
2. Production of infectious particles from defective human immunodeficiency virus type 1 (HIV-1)-producing cell clones by superinfection with infectious HIV-1.
Yunoki M; Maotani-Imai K; Kusuda H; Motoyama M; Miyake S; Imai H; Shin YS; Kato S; Sano K; Morita C
Arch Virol; 1991; 116(1-4):143-58. PubMed ID: 2001175
[TBL] [Abstract][Full Text] [Related]
3. The life-cycle of human immunodeficiency virus type 1.
Goto T; Nakai M; Ikuta K
Micron; 1998; 29(2-3):123-38. PubMed ID: 9684349
[TBL] [Abstract][Full Text] [Related]
4. Ultrastructure and morphogenesis of human immunodeficiency virus.
Nakai M; Goto T
J Electron Microsc (Tokyo); 1996 Aug; 45(4):247-57. PubMed ID: 8888583
[TBL] [Abstract][Full Text] [Related]
5. Isolation and characterization of cell clones persistently producing teardrop-shaped particles of human immunodeficiency virus type 1.
Morita C; Ikuta K; Goto T; Sano K; Nakai M; Hirai K; Kato S
J Acquir Immune Defic Syndr (1988); 1990; 3(3):231-7. PubMed ID: 2106023
[TBL] [Abstract][Full Text] [Related]
6. Cells surviving infection by human immunodeficiency virus type 1: vif or vpu mutants produce non-infectious or markedly less cytopathic viruses.
Kishi M; Nishino Y; Sumiya M; Ohki K; Kimura T; Goto T; Nakai M; Kakinuma M; Ikuta K
J Gen Virol; 1992 Jan; 73 ( Pt 1)():77-87. PubMed ID: 1730943
[TBL] [Abstract][Full Text] [Related]
7. Noninfectious doughnut-shaped human immunodeficiency virus type 1 can induce syncytia mediated by fusion of the particles with CD4-positive cells.
Ohki K; Kishi Y; Nishino Y; Sumiya M; Kimura T; Goto T; Nakai M; Ikuta K
J Acquir Immune Defic Syndr (1988); 1991; 4(12):1233-40. PubMed ID: 1682474
[TBL] [Abstract][Full Text] [Related]
8. Budding process and maturation of human immunodeficiency virus examined by means of pre- and post-embedding immunocolloidal gold electron microscopy.
Katsumoto T; Asanaka M; Kageyama S; Kurimura T; Nakajima K; Noto A; Tanaka H; Sato R
J Electron Microsc (Tokyo); 1990; 39(1):33-8. PubMed ID: 2358770
[TBL] [Abstract][Full Text] [Related]
9. Formation of noninfectious HIV-1 virus particles lacking a full-length envelope protein.
Ratner L; Vander Heyden N; Garcia J; Polinsky M; Westervelt P; Becich M
AIDS Res Hum Retroviruses; 1991 Mar; 7(3):287-94. PubMed ID: 1829617
[TBL] [Abstract][Full Text] [Related]
10. Defective human immunodeficiency virus (HIV) particles produced by cloned cells of HTLV-I-carrying MT-4 cells persistently infected with HIV.
Ikuta K; Morita C; Nakai M; Yamamoto N; Kato S
Jpn J Cancer Res; 1988 Apr; 79(4):418-23. PubMed ID: 2898463
[TBL] [Abstract][Full Text] [Related]
11. Human immunodeficiency virus-like particles produced by a vaccinia virus expression vector.
Karacostas V; Nagashima K; Gonda MA; Moss B
Proc Natl Acad Sci U S A; 1989 Nov; 86(22):8964-7. PubMed ID: 2479031
[TBL] [Abstract][Full Text] [Related]
12. Expression of human immunodeficiency virus type 1 (HIV-1) gag antigens on the surface of a cell line persistently infected with HIV-1 that highly expresses HIV-1 antigens.
Ikuta K; Morita C; Miyake S; Ito T; Okabayashi M; Sano K; Nakai M; Hirai K; Kato S
Virology; 1989 Jun; 170(2):408-17. PubMed ID: 2499113
[TBL] [Abstract][Full Text] [Related]
13. Analysis of protein expression and virus-like particle formation in mammalian cell lines stably expressing HIV-1 gag and env gene products with or without active HIV proteinase.
Kräusslich HG; Ochsenbauer C; Traenckner AM; Mergener K; Fäcke M; Gelderblom HR; Bosch V
Virology; 1993 Feb; 192(2):605-17. PubMed ID: 8421902
[TBL] [Abstract][Full Text] [Related]
14. Ultrastructure of human retroviruses.
Palmer E; Goldsmith CS
J Electron Microsc Tech; 1988 Jan; 8(1):3-15. PubMed ID: 2854553
[TBL] [Abstract][Full Text] [Related]
15. Superinfection of defective human immunodeficiency virus type 1 with different subtypes of wild-type virus efficiently produces infectious variants with the initial viral phenotypes by complementation followed by recombination.
Iwabu Y; Mizuta H; Kawase M; Kameoka M; Goto T; Ikuta K
Microbes Infect; 2008 Apr; 10(5):504-13. PubMed ID: 18403230
[TBL] [Abstract][Full Text] [Related]
16. Role of vif during packing of the core of HIV-1.
Höglund S; Ohagen A; Lawrence K; Gabuzda D
Virology; 1994 Jun; 201(2):349-55. PubMed ID: 8184544
[TBL] [Abstract][Full Text] [Related]
17. Cleavage of Gag precursor is required for early replication phase of HIV-1.
Kawamura M; Shimano R; Inubushi R; Amano K; Ogasawara T; Akari H; Adachi A
FEBS Lett; 1997 Sep; 415(2):227-30. PubMed ID: 9351001
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of human immunodeficiency virus type 1 infectivity by replacing the region including Env derived from defective particles with an ability to form particle-mediated syncytia in CD4+T cells.
Kinomoto M; Mukai T; Li YG; Iwabu Y; Warachit J; Palacios JA; Ibrahim MS; Tsuji S; Goto T; Ikuta K
Microbes Infect; 2004 Aug; 6(10):911-8. PubMed ID: 15310467
[TBL] [Abstract][Full Text] [Related]
19. Maturation of human immunodeficiency virus, strain LAV, in vitro.
Katsumoto T; Hattori N; Kurimura T
Intervirology; 1987; 27(3):148-53. PubMed ID: 3667187
[TBL] [Abstract][Full Text] [Related]
20. Budding process and fine structure of lymphadenopathy-associated virus (LAV).
Tsuchie H; Katsumoto T; Hattori N; Kawatani T; Kurimura T; Hinuma Y
Microbiol Immunol; 1986; 30(6):545-52. PubMed ID: 3018458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
